The global market for Chronic Kidney Disease (CKD) Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Treatment of Chronic Kidney Disease includes:

Lifestyle changes – to help you stay as healthy as possible

Medicine – to control associated problems, such as high blood pressure and high cholesterol

Dialysis – treatment to replicate some of the kidney"s functions, which may be necessary in advanced (stage 5) CKD

Kidney transplant – this may also be necessary in advanced (stage 5) CKD.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease (CKD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease (CKD) Treatment.

The Chronic Kidney Disease (CKD) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Kidney Disease (CKD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Kidney Disease (CKD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Kidney Disease (CKD) Treatment Market Report

Report Metric	Details
Report Name	Chronic Kidney Disease (CKD) Treatment Market
CAGR	5%
Segment by Type	Medicine Hemodialysis Peritoneal Dialysis Kidney Transplantation
Segment by Application	Hospitals Kidney Dialysis Centers At Homes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical, AstraZeneca, Vifor Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Kidney Disease (CKD) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Kidney Disease (CKD) Treatment Market report?

Ans: The main players in the Chronic Kidney Disease (CKD) Treatment Market are Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical, AstraZeneca, Vifor Pharma

What are the Application segmentation covered in the Chronic Kidney Disease (CKD) Treatment Market report?

Ans: The Applications covered in the Chronic Kidney Disease (CKD) Treatment Market report are Hospitals, Kidney Dialysis Centers, At Homes, Others

What are the Type segmentation covered in the Chronic Kidney Disease (CKD) Treatment Market report?

Ans: The Types covered in the Chronic Kidney Disease (CKD) Treatment Market report are Medicine, Hemodialysis, Peritoneal Dialysis, Kidney Transplantation

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Medicine

1.2.3 Hemodialysis

1.2.4 Peritoneal Dialysis

1.2.5 Kidney Transplantation

1.3 Market by Application

1.3.1 Global Chronic Kidney Disease (CKD) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Kidney Dialysis Centers

1.3.4 At Homes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Kidney Disease (CKD) Treatment Market Perspective (2020-2031)

2.2 Global Chronic Kidney Disease (CKD) Treatment Growth Trends by Region

2.2.1 Global Chronic Kidney Disease (CKD) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chronic Kidney Disease (CKD) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Chronic Kidney Disease (CKD) Treatment Market Dynamics

2.3.1 Chronic Kidney Disease (CKD) Treatment Industry Trends

2.3.2 Chronic Kidney Disease (CKD) Treatment Market Drivers

2.3.3 Chronic Kidney Disease (CKD) Treatment Market Challenges

2.3.4 Chronic Kidney Disease (CKD) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Kidney Disease (CKD) Treatment Players by Revenue

3.1.1 Global Top Chronic Kidney Disease (CKD) Treatment Players by Revenue (2020-2025)

3.1.2 Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Chronic Kidney Disease (CKD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chronic Kidney Disease (CKD) Treatment Revenue

3.4 Global Chronic Kidney Disease (CKD) Treatment Market Concentration Ratio

3.4.1 Global Chronic Kidney Disease (CKD) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Treatment Revenue in 2024

3.5 Global Key Players of Chronic Kidney Disease (CKD) Treatment Head office and Area Served

3.6 Global Key Players of Chronic Kidney Disease (CKD) Treatment, Product and Application

3.7 Global Key Players of Chronic Kidney Disease (CKD) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Kidney Disease (CKD) Treatment Breakdown Data by Type

4.1 Global Chronic Kidney Disease (CKD) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Type (2026-2031)

5 Chronic Kidney Disease (CKD) Treatment Breakdown Data by Application

5.1 Global Chronic Kidney Disease (CKD) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chronic Kidney Disease (CKD) Treatment Market Size (2020-2031)

6.2 North America Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025)

6.4 North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Kidney Disease (CKD) Treatment Market Size (2020-2031)

7.2 Europe Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025)

7.4 Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Kidney Disease (CKD) Treatment Market Size (2020-2031)

9.2 Latin America Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025)

9.4 Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fresenius

11.1.1 Fresenius Company Details

11.1.2 Fresenius Business Overview

11.1.3 Fresenius Chronic Kidney Disease (CKD) Treatment Introduction

11.1.4 Fresenius Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.1.5 Fresenius Recent Development

11.2 DaVita

11.2.1 DaVita Company Details

11.2.2 DaVita Business Overview

11.2.3 DaVita Chronic Kidney Disease (CKD) Treatment Introduction

11.2.4 DaVita Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.2.5 DaVita Recent Development

11.3 Baxter

11.3.1 Baxter Company Details

11.3.2 Baxter Business Overview

11.3.3 Baxter Chronic Kidney Disease (CKD) Treatment Introduction

11.3.4 Baxter Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.3.5 Baxter Recent Development

11.4 Nipro

11.4.1 Nipro Company Details

11.4.2 Nipro Business Overview

11.4.3 Nipro Chronic Kidney Disease (CKD) Treatment Introduction

11.4.4 Nipro Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.4.5 Nipro Recent Development

11.5 B. Braun

11.5.1 B. Braun Company Details

11.5.2 B. Braun Business Overview

11.5.3 B. Braun Chronic Kidney Disease (CKD) Treatment Introduction

11.5.4 B. Braun Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.5.5 B. Braun Recent Development

11.6 Asahi Kasei

11.6.1 Asahi Kasei Company Details

11.6.2 Asahi Kasei Business Overview

11.6.3 Asahi Kasei Chronic Kidney Disease (CKD) Treatment Introduction

11.6.4 Asahi Kasei Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.6.5 Asahi Kasei Recent Development

11.7 Nikkiso

11.7.1 Nikkiso Company Details

11.7.2 Nikkiso Business Overview

11.7.3 Nikkiso Chronic Kidney Disease (CKD) Treatment Introduction

11.7.4 Nikkiso Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.7.5 Nikkiso Recent Development

11.8 WEGO

11.8.1 WEGO Company Details

11.8.2 WEGO Business Overview

11.8.3 WEGO Chronic Kidney Disease (CKD) Treatment Introduction

11.8.4 WEGO Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.8.5 WEGO Recent Development

11.9 Newsol

11.9.1 Newsol Company Details

11.9.2 Newsol Business Overview

11.9.3 Newsol Chronic Kidney Disease (CKD) Treatment Introduction

11.9.4 Newsol Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.9.5 Newsol Recent Development

11.10 Mayo Clinic

11.10.1 Mayo Clinic Company Details

11.10.2 Mayo Clinic Business Overview

11.10.3 Mayo Clinic Chronic Kidney Disease (CKD) Treatment Introduction

11.10.4 Mayo Clinic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.10.5 Mayo Clinic Recent Development

11.11 Guangdong Biolight

11.11.1 Guangdong Biolight Company Details

11.11.2 Guangdong Biolight Business Overview

11.11.3 Guangdong Biolight Chronic Kidney Disease (CKD) Treatment Introduction

11.11.4 Guangdong Biolight Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.11.5 Guangdong Biolight Recent Development

11.12 Medtronic

11.12.1 Medtronic Company Details

11.12.2 Medtronic Business Overview

11.12.3 Medtronic Chronic Kidney Disease (CKD) Treatment Introduction

11.12.4 Medtronic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.12.5 Medtronic Recent Development

11.13 Sanxin Medtec

11.13.1 Sanxin Medtec Company Details

11.13.2 Sanxin Medtec Business Overview

11.13.3 Sanxin Medtec Chronic Kidney Disease (CKD) Treatment Introduction

11.13.4 Sanxin Medtec Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.13.5 Sanxin Medtec Recent Development

11.14 Jafron Biomedical

11.14.1 Jafron Biomedical Company Details

11.14.2 Jafron Biomedical Business Overview

11.14.3 Jafron Biomedical Chronic Kidney Disease (CKD) Treatment Introduction

11.14.4 Jafron Biomedical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.14.5 Jafron Biomedical Recent Development

11.15 SWS Hemodialysis Care

11.15.1 SWS Hemodialysis Care Company Details

11.15.2 SWS Hemodialysis Care Business Overview

11.15.3 SWS Hemodialysis Care Chronic Kidney Disease (CKD) Treatment Introduction

11.15.4 SWS Hemodialysis Care Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.15.5 SWS Hemodialysis Care Recent Development

11.16 Tianyi Medical

11.16.1 Tianyi Medical Company Details

11.16.2 Tianyi Medical Business Overview

11.16.3 Tianyi Medical Chronic Kidney Disease (CKD) Treatment Introduction

11.16.4 Tianyi Medical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.16.5 Tianyi Medical Recent Development

11.17 AstraZeneca

11.17.1 AstraZeneca Company Details

11.17.2 AstraZeneca Business Overview

11.17.3 AstraZeneca Chronic Kidney Disease (CKD) Treatment Introduction

11.17.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.17.5 AstraZeneca Recent Development

11.18 Vifor Pharma

11.18.1 Vifor Pharma Company Details

11.18.2 Vifor Pharma Business Overview

11.18.3 Vifor Pharma Chronic Kidney Disease (CKD) Treatment Introduction

11.18.4 Vifor Pharma Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

11.18.5 Vifor Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

SWS Hemodialysis Care

Tianyi Medical

Astrazeneca plc

Vifor Pharma

List of Tables

Table 1. Global Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Medicine

Table 3. Key Players of Hemodialysis

Table 4. Key Players of Peritoneal Dialysis

Table 5. Key Players of Kidney Transplantation

Table 6. Global Chronic Kidney Disease (CKD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Chronic Kidney Disease (CKD) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Chronic Kidney Disease (CKD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region (2020-2025)

Table 10. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region (2026-2031)

Table 12. Chronic Kidney Disease (CKD) Treatment Market Trends

Table 13. Chronic Kidney Disease (CKD) Treatment Market Drivers

Table 14. Chronic Kidney Disease (CKD) Treatment Market Challenges

Table 15. Chronic Kidney Disease (CKD) Treatment Market Restraints

Table 16. Global Chronic Kidney Disease (CKD) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Chronic Kidney Disease (CKD) Treatment Market Share by Players (2020-2025)

Table 18. Global Top Chronic Kidney Disease (CKD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Treatment as of 2024)

Table 19. Ranking of Global Top Chronic Kidney Disease (CKD) Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Chronic Kidney Disease (CKD) Treatment, Headquarters and Area Served

Table 22. Global Key Players of Chronic Kidney Disease (CKD) Treatment, Product and Application

Table 23. Global Key Players of Chronic Kidney Disease (CKD) Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Chronic Kidney Disease (CKD) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Chronic Kidney Disease (CKD) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Fresenius Company Details

Table 49. Fresenius Business Overview

Table 50. Fresenius Chronic Kidney Disease (CKD) Treatment Product

Table 51. Fresenius Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 52. Fresenius Recent Development

Table 53. DaVita Company Details

Table 54. DaVita Business Overview

Table 55. DaVita Chronic Kidney Disease (CKD) Treatment Product

Table 56. DaVita Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 57. DaVita Recent Development

Table 58. Baxter Company Details

Table 59. Baxter Business Overview

Table 60. Baxter Chronic Kidney Disease (CKD) Treatment Product

Table 61. Baxter Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 62. Baxter Recent Development

Table 63. Nipro Company Details

Table 64. Nipro Business Overview

Table 65. Nipro Chronic Kidney Disease (CKD) Treatment Product

Table 66. Nipro Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 67. Nipro Recent Development

Table 68. B. Braun Company Details

Table 69. B. Braun Business Overview

Table 70. B. Braun Chronic Kidney Disease (CKD) Treatment Product

Table 71. B. Braun Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 72. B. Braun Recent Development

Table 73. Asahi Kasei Company Details

Table 74. Asahi Kasei Business Overview

Table 75. Asahi Kasei Chronic Kidney Disease (CKD) Treatment Product

Table 76. Asahi Kasei Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 77. Asahi Kasei Recent Development

Table 78. Nikkiso Company Details

Table 79. Nikkiso Business Overview

Table 80. Nikkiso Chronic Kidney Disease (CKD) Treatment Product

Table 81. Nikkiso Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 82. Nikkiso Recent Development

Table 83. WEGO Company Details

Table 84. WEGO Business Overview

Table 85. WEGO Chronic Kidney Disease (CKD) Treatment Product

Table 86. WEGO Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 87. WEGO Recent Development

Table 88. Newsol Company Details

Table 89. Newsol Business Overview

Table 90. Newsol Chronic Kidney Disease (CKD) Treatment Product

Table 91. Newsol Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 92. Newsol Recent Development

Table 93. Mayo Clinic Company Details

Table 94. Mayo Clinic Business Overview

Table 95. Mayo Clinic Chronic Kidney Disease (CKD) Treatment Product

Table 96. Mayo Clinic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 97. Mayo Clinic Recent Development

Table 98. Guangdong Biolight Company Details

Table 99. Guangdong Biolight Business Overview

Table 100. Guangdong Biolight Chronic Kidney Disease (CKD) Treatment Product

Table 101. Guangdong Biolight Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 102. Guangdong Biolight Recent Development

Table 103. Medtronic Company Details

Table 104. Medtronic Business Overview

Table 105. Medtronic Chronic Kidney Disease (CKD) Treatment Product

Table 106. Medtronic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 107. Medtronic Recent Development

Table 108. Sanxin Medtec Company Details

Table 109. Sanxin Medtec Business Overview

Table 110. Sanxin Medtec Chronic Kidney Disease (CKD) Treatment Product

Table 111. Sanxin Medtec Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 112. Sanxin Medtec Recent Development

Table 113. Jafron Biomedical Company Details

Table 114. Jafron Biomedical Business Overview

Table 115. Jafron Biomedical Chronic Kidney Disease (CKD) Treatment Product

Table 116. Jafron Biomedical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 117. Jafron Biomedical Recent Development

Table 118. SWS Hemodialysis Care Company Details

Table 119. SWS Hemodialysis Care Business Overview

Table 120. SWS Hemodialysis Care Chronic Kidney Disease (CKD) Treatment Product

Table 121. SWS Hemodialysis Care Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 122. SWS Hemodialysis Care Recent Development

Table 123. Tianyi Medical Company Details

Table 124. Tianyi Medical Business Overview

Table 125. Tianyi Medical Chronic Kidney Disease (CKD) Treatment Product

Table 126. Tianyi Medical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 127. Tianyi Medical Recent Development

Table 128. AstraZeneca Company Details

Table 129. AstraZeneca Business Overview

Table 130. AstraZeneca Chronic Kidney Disease (CKD) Treatment Product

Table 131. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 132. AstraZeneca Recent Development

Table 133. Vifor Pharma Company Details

Table 134. Vifor Pharma Business Overview

Table 135. Vifor Pharma Chronic Kidney Disease (CKD) Treatment Product

Table 136. Vifor Pharma Revenue in Chronic Kidney Disease (CKD) Treatment Business (2020-2025) & (US$ Million)

Table 137. Vifor Pharma Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Chronic Kidney Disease (CKD) Treatment Picture

Figure 2. Global Chronic Kidney Disease (CKD) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Kidney Disease (CKD) Treatment Market Share by Type: 2024 VS 2031

Figure 4. Medicine Features

Figure 5. Hemodialysis Features

Figure 6. Peritoneal Dialysis Features

Figure 7. Kidney Transplantation Features

Figure 8. Global Chronic Kidney Disease (CKD) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Chronic Kidney Disease (CKD) Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Kidney Dialysis Centers Case Studies

Figure 12. At Homes Case Studies

Figure 13. Others Case Studies

Figure 14. Chronic Kidney Disease (CKD) Treatment Report Years Considered

Figure 15. Global Chronic Kidney Disease (CKD) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Chronic Kidney Disease (CKD) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Chronic Kidney Disease (CKD) Treatment Market Share by Players in 2024

Figure 19. Global Top Chronic Kidney Disease (CKD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Treatment Revenue in 2024

Figure 21. North America Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Chronic Kidney Disease (CKD) Treatment Market Share by Country (2020-2031)

Figure 23. United States Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Chronic Kidney Disease (CKD) Treatment Market Share by Country (2020-2031)

Figure 27. Germany Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Share by Region (2020-2031)

Figure 35. China Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Chronic Kidney Disease (CKD) Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Fresenius Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 51. DaVita Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 52. Baxter Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 53. Nipro Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 54. B. Braun Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 55. Asahi Kasei Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 56. Nikkiso Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 57. WEGO Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 58. Newsol Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 59. Mayo Clinic Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 60. Guangdong Biolight Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 61. Medtronic Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 62. Sanxin Medtec Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 63. Jafron Biomedical Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 64. SWS Hemodialysis Care Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 65. Tianyi Medical Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 66. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 67. Vifor Pharma Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024

Global CKD and ESRD Treatment Market Research Report 2025

Global Renal Therapeutic Market Research Report 2025

Global Chronic Disease Treatment Market Research Report 2024

Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease Nutritional Supplement Market Research Report 2024

Global Renal Disease Treatment Market Research Report 2024

Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Kidney Renal Fibrosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Medicine Market Insights Forecast to 2030

End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Kidney Disease Drugs Market Research Report 2025

Global Renal Medical Devices Market Research Report 2024

Renal Dialysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dialysis Device And Concentrates Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-036

Mon Apr 21 00:00:00 UTC 2025

Add to Cart

Global Asthma Metered Dose Inhalers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z18866

Mon Apr 21 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17W2541

Mon Apr 21 00:00:00 UTC 2025

Add to Cart

Global Blood Glucose Meters and Strips and Continuous Glucose Monitoring Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z6655

Mon Apr 21 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »

Global Chronic Kidney Disease (CKD) Treatment Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-2D10770

Global Chronic Kidney Disease (CKD) Treatment Market Research Report 2025

FEATURED COMPANIES

Chronic Kidney Disease (CKD) Treatment Market Size

Chronic Kidney Disease (CKD) Treatment Market

Scope of Chronic Kidney Disease (CKD) Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Chronic Kidney Disease (CKD) Treatment Market report?

What are the Application segmentation covered in the Chronic Kidney Disease (CKD) Treatment Market report?

What are the Type segmentation covered in the Chronic Kidney Disease (CKD) Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS